Cervical Cancer

The Pharmacy Times® Cervical Cancer Resource Center is a comprehensive resource for clinical news and expert insights for the type of cancer that occurs in the cells of the cervix.

Latest News

Vaccination in the shoulder | Image Credit: Alex Photo - stock.adobe.com
Merck Announces Initiation of Clinical Development for Investigational HPV Vaccine

March 21st 2024

Merck will also conduct clinical trials in both males and females to evaluate the efficacy of a single dose of their current human papillomavirus vaccine compared with the approved 3-dose regimen.

There Is a Need for Better CIN Therapies to Prevent Cervical Cancer
There Is a Need for Better CIN Therapies to Prevent Cervical Cancer

March 20th 2024

Senior Woman Undergoing Chemotherapy With Nurse | Image Credit: Monkey Business - stock.adobe.com
Pembrolizumab, Chemoradiotherapy Meet Overall Survival Endpoint for Cervical Cancer

March 20th 2024

Female Reproductive System Anatomy - Image credit: mi_viri | stock.adobe.com
FDA Approves Pembrolizumab Plus Chemoradiotherapy to Treat FIGO 2014 Stage III-IVA Cervical Cancer

January 15th 2024

FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer
FDA Accepts sBLA for Tisotumab Vedotin-tftv for the Treatment of Recurrent, Metastatic Cervical Cancer

January 9th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.